Drugs / rCSP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03589794 | Dec 2018 → Jul 2022 | Plasmodium falciparum malaria | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rCSP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03589794 ↗ |
| Modality | Vaccine | “rCSP malaria vaccine” NCT03589794 ↗ |
| Route | Intramuscular | “intramuscularly (IM)” NCT03589794 ↗ |